Pharmacokinetic and Pharmacodynamic Properties of Single- and Multiple-Dose of Dapagliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese SubjectsYang Li, David W. Boulton, Hongmei Li et al.|Clinical Therapeutics|2013Cited by 43